Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
2
×
aldehyde
aldeyra therapeutics
allergic conjunctivitis
biotech
boston
boston blog main
boston top stories
clinical study
clinical trials
data
disease
drugs
dry eye disease
enzyme
gag
gene editing
genome editing
hunter syndrome
ids
mps ii
mucopolysaccharidosis ii
national top stories
reproxalab
san francisco
san francisco blog main
san francisco top stories
sandy macrae
sangamo therapeutics
sjogren-larsson syndrome
studies
zinc finger nucleases
What
medicine
2
×
phase
2
×
results
therapeutics
aldeyra
benefit
closer
data
disclosed
drug
editing
eye
fda
fighting
filing
gene
going
humans
inflammation
isn't
landmark
little
morning
multiple
nasdaq
new
positive
puts
reported
reports
sangamo
step
studies
study
trial
type
u.s
Language
Current search:
phase
×
medicine
×
" national blog main "
×
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
